Immunovant (IMVT) Q1 2026 Earnings

Feb 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.73
-0.69
-0.65
-0.61

Details

Expected EPS
-0.713433
Actual EPS
-0.61
Surprise EPS
0.1
Surprise Percent
+14.5%

Description

⁨Immunovant⁩ (⁦IMVT⁩) has reported earnings of ⁦-0.61⁩ per share for ⁦Q1 2026⁩.

0 Comments

Share your thoughts